![](https://wp-static.smartkarma.com/../assets/uploaded/2022/07/TMTSenseTimeGroupFUJIFILMHoldingsandmore.png)
In today’s briefing:
- SenseTime: Shares Fall with Lock-Up Expiry; Further Downside with More Selling at the Next Expiry
- Fujifilm (4901) | Bio Pharma Giant Is a Double
SenseTime: Shares Fall with Lock-Up Expiry; Further Downside with More Selling at the Next Expiry
- AI software company SenseTime’s share price dropped more than 50% over the last one week with the expiry of lock-up period as pre-investors of the company took some profits.
- The company was placed in an investment blacklist by the US government prior to the IPO which forced to launch the IPO without investors from the US.
- The company also priced the IPO at the bottom of the price range and despite all of this, shares quickly went up to HK$8.20 from IPO price of US$3.85.
Fujifilm (4901) | Bio Pharma Giant Is a Double
- It is time to throw off the old valuation models. Fujifilm is no longer a dusty old camera maker
- The healthcare business is already the biggest earnings driver and with aggressive capex….
- Fujifilm will become the biggest biopharma contract manufacturing company in the world. Valuations don’t reflect that.
Before it’s here, it’s on Smartkarma